Literature DB >> 19860627

Analysis of prognostic factors in peripheral T-cell lymphoma: prognostic value of serum albumin and mediastinal lymphadenopathy.

Dai Chihara1, Yasuhiro Oki, Shouji Ine, Kazuhito Yamamoto, Harumi Kato, Hirofumi Taji, Yoshitoyo Kagami, Yasushi Yatabe, Shigeo Nakamura, Yasuo Morishima.   

Abstract

We evaluated multiple patient characteristics for their prognostic significance in patients with peripheral T-cell lymphoma (angioimmunoblastic T-cell lymphoma [AITL; n = 31] and peripheral T-cell lymphoma, not otherwise unspecified [PTCL-NOS; n = 37]). Five-year overall survival (OS) rates in AITL and PTCL-NOS were 49% and 45%, respectively (p = 0.89). Cox proportional hazard model revealed that male sex, hemoglobin <10.0 g/dL and performance status (PS) > or =2 were independently associated with shorter OS in AITL. In patients with PTCL-NOS, low albumin, PS > or = 2, and mediastinal lymphadenopathy were independently associated with worse OS. When analysis in PTCL-NOS was performed incorporating Prognostic Index for PTCLu (PIT), low albumin and mediastinal lymphadenopathy were still both prognostic for OS. Three-year progression free survival (PFS) rates in AITL and PTCL-NOS were 49% and 47%, respectively (p = 0.578). None of the parameters was significantly associated with shorter PFS in AITL. In patients with PTCL-NOS, PS > or = 2 and mediastinal lymphadenopathy were independently associated with shorter PFS. The result is in keeping with previous large scale studies. Besides, we showed the potential prognostic importance of albumin and mediastinal lymphadenopathy in patients with PTCL-NOS.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19860627     DOI: 10.3109/10428190903318311

Source DB:  PubMed          Journal:  Leuk Lymphoma        ISSN: 1026-8022


  10 in total

1.  Primary mediastinal large B-cell lymphoma (PMLBCL) in Chinese patients: clinical characteristics and prognostic factors.

Authors:  Ying-Jie Zhu; Jia-Jia Huang; Yi Xia; Wei Zhao; Wen-Qi Jiang; Tong-Yu Lin; Hui-Qiang Huang; Zhi-Ming Li
Journal:  Int J Hematol       Date:  2011-07-29       Impact factor: 2.490

2.  Evolving Therapy of Peripheral T-cell Lymphoma: 2010 and beyond.

Authors:  Francine Foss
Journal:  Ther Adv Hematol       Date:  2011-06

3.  Association of ST-T changes with all-cause mortality among patients with peripheral T-cell lymphomas.

Authors:  Hanzhi Du; Lihong Yang; Bin Yan; Juan Zhao; Mengchang Wang
Journal:  Open Med (Wars)       Date:  2022-07-12

Review 4.  Geriatric assessment in older adults with non-Hodgkin lymphoma: A Young International Society of Geriatric Oncology (YSIOG) review paper.

Authors:  Othman Salim Akhtar; Li-Wen Huang; Mazie Tsang; Pallawi Torka; Kah Poh Loh; Vicki A Morrison; Raul Cordoba
Journal:  J Geriatr Oncol       Date:  2022-02-23       Impact factor: 3.929

5.  A new prognostic score comprising lactate dehydrogenase, albumin and neutrophil to lymphocyte ratio to predict sensitivity to first-line chemotherapy in patients with peripheral T-cell lymphomas.

Authors:  Satoshi Kaito; Yusuke Kanemasa; Yuki Sasaki; Toshihiro Okuya; Tsukasa Yamaguchi; Chikako Funasaka; Tatsu Shimoyama; Yasushi Omuro; Tsunekazu Hishima; Yoshiharu Maeda
Journal:  Int J Hematol       Date:  2017-11-04       Impact factor: 2.490

6.  Evaluation of prognostic factors and the role of chemotherapy in unfavorable carcinoma of unknown primary site: a 10-year cohort study.

Authors:  Kuo-Wei Chen; Chia-Jen Liu; Hsueh-Ju Lu; Cheng-Hwai Tzeng; Jin-Hwang Liu; Tzeon-Jye Chiou; Chueh-Chuan Yen; Wei-Shu Wang; Ta-Chung Chao; Hao-Wei Teng; Ming-Huang Chen; Chun-Yu Liu; Peter Mu-Hsin Chang; Muh-Hwa Yang
Journal:  BMC Res Notes       Date:  2012-01-26

7.  The role of front-line anthracycline-containing chemotherapy regimens in peripheral T-cell lymphomas.

Authors:  R Briski; A L Feldman; N G Bailey; M S Lim; K Ristow; T M Habermann; W R Macon; D J Inwards; J P Colgan; G S Nowakowski; M S Kaminski; T E Witzig; S M Ansell; R A Wilcox
Journal:  Blood Cancer J       Date:  2014-05-30       Impact factor: 11.037

8.  Peripheral T cell lymphoma, not otherwise specified (PTCL-NOS). A new prognostic model developed by the International T cell Project Network.

Authors:  Massimo Federico; Monica Bellei; Luigi Marcheselli; Marc Schwartz; Martina Manni; Vittoria Tarantino; Stefano Pileri; Young-Hyeh Ko; Maria E Cabrera; Steven Horwitz; Won S Kim; Andrei Shustov; Francine M Foss; Arnon Nagler; Kenneth Carson; Lauren C Pinter-Brown; Silvia Montoto; Michele Spina; Tatyana A Feldman; Mary J Lechowicz; Sonali M Smith; Frederick Lansigan; Raul Gabus; Julie M Vose; Ranjana H Advani
Journal:  Br J Haematol       Date:  2018-04-19       Impact factor: 6.998

Review 9.  Host-related factors and cancer: Malnutrition and non-Hodgkin lymphoma.

Authors:  Salvatrice Mancuso; Marta Mattana; Marco Santoro; Melania Carlisi; Silvio Buscemi; Sergio Siragusa
Journal:  Hematol Oncol       Date:  2022-04-18       Impact factor: 4.850

10.  Pretreatment Epstein-Barr virus DNA in whole blood is a prognostic marker in peripheral T-cell lymphoma.

Authors:  Yu Ri Kim; Soo-Jeong Kim; June-Won Cheong; Haerim Chung; Ji Eun Jang; Yundeok Kim; Woo-Ick Yang; Yoo Hong Min; Jin Seok Kim
Journal:  Oncotarget       Date:  2017-09-23
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.